325 related articles for article (PubMed ID: 22618509)
21. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
23. Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
Jiang M; Zhang P; Hu G; Xiao Z; Xu F; Zhong T; Huang F; Kuang H; Zhang W
Mol Cell Biochem; 2013 Nov; 383(1-2):67-75. PubMed ID: 23881177
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA expression differentiates histology and predicts survival of lung cancer.
Landi MT; Zhao Y; Rotunno M; Koshiol J; Liu H; Bergen AW; Rubagotti M; Goldstein AM; Linnoila I; Marincola FM; Tucker MA; Bertazzi PA; Pesatori AC; Caporaso NE; McShane LM; Wang E
Clin Cancer Res; 2010 Jan; 16(2):430-41. PubMed ID: 20068076
[TBL] [Abstract][Full Text] [Related]
25. ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
Tessema M; Yingling CM; Picchi MA; Wu G; Ryba T; Lin Y; Bungum AO; Edell ES; Spira A; Belinsky SA
Cancer Lett; 2017 Dec; 410():191-200. PubMed ID: 28965852
[TBL] [Abstract][Full Text] [Related]
26. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
[TBL] [Abstract][Full Text] [Related]
27. miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.
Tejero R; Navarro A; Campayo M; Viñolas N; Marrades RM; Cordeiro A; Ruíz-Martínez M; Santasusagna S; Molins L; Ramirez J; Monzó M
PLoS One; 2014; 9(7):e101899. PubMed ID: 25003366
[TBL] [Abstract][Full Text] [Related]
28. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
29. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs associated with increased AKT gene number in human lung carcinoma.
Goto A; Dobashi Y; Tsubochi H; Maeda D; Ooi A
Hum Pathol; 2016 Oct; 56():1-10. PubMed ID: 27189341
[TBL] [Abstract][Full Text] [Related]
31. Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing.
Ma J; Mannoor K; Gao L; Tan A; Guarnera MA; Zhan M; Shetty A; Stass SA; Xing L; Jiang F
Mol Oncol; 2014 Oct; 8(7):1208-19. PubMed ID: 24785186
[TBL] [Abstract][Full Text] [Related]
32. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
[TBL] [Abstract][Full Text] [Related]
33. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
Deng B; Sun Z; Jason W; Yang P
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
35. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
37. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
[TBL] [Abstract][Full Text] [Related]
40. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
